Diversity of the Human Gastrointestinal Microbiota Novel Perspectives from High Throughput Analyses

Total Page:16

File Type:pdf, Size:1020Kb

Diversity of the Human Gastrointestinal Microbiota Novel Perspectives from High Throughput Analyses Diversity of the Human Gastrointestinal Microbiota Novel Perspectives from High Throughput Analyses Mirjana Rajilić-Stojanović Promotor Prof. Dr W. M. de Vos Hoogleraar Microbiologie Wageningen Universiteit Samenstelling Promotiecommissie Prof. Dr T. Abee Wageningen Universiteit Dr J. Doré INRA, France Prof. Dr G. R. Gibson University of Reading, UK Prof. Dr S. Salminen University of Turku, Finland Dr K. Venema TNO Quality for life, Zeist Dit onderzoek is uitgevoerd binnen de onderzoekschool VLAG. Diversity of the Human Gastrointestinal Microbiota Novel Perspectives from High Throughput Analyses Mirjana Rajilić-Stojanović Proefschrift Ter verkrijging van de graad van doctor op gezag van de rector magnificus van Wageningen Universiteit, Prof. dr. M. J. Kropff, in het openbaar te verdedigen op maandag 11 juni 2007 des namiddags te vier uur in de Aula Mirjana Rajilić-Stojanović, Diversity of the Human Gastrointestinal Microbiota – Novel Perspectives from High Throughput Analyses (2007) PhD Thesis, Wageningen University and Research Centre, Wageningen, The Netherlands – with Summary in Dutch – 214 p. ISBN: 978-90-8504-663-9 Abstract The human gastrointestinal tract is densely populated by hundreds of microbial (primarily bacterial, but also archaeal and fungal) species that are collectively named the microbiota. This microbiota performs various functions and contributes significantly to the digestion and the health of the host. It has previously been noted that the diversity of the gastrointestinal microbiota is disturbed in relation to several intestinal and not intestine related diseases. However, accurate and detailed defining of such disturbances is hampered by the fact that the diversity of this ecosystem is still not fully described, primarily because of its extreme complexity, and high inter-individual variability. The work presented in this thesis summarises the hitherto gathered knowledge on the diversity of the human gastrointestinal microbiota based on an extensive literature search that aimed to gather all reports of microbial life within the gastrointestinal tract starting from the first isolation in 1885. This resulted in the construction of the ecosystem-specific database of small subunit ribosomal RNA sequences of over 1,000 human gastrointestinal inhabitants based on which a phylogenetic microarray was designed. This newly developed HITChip (Human Intestinal Tract Chip) enabled comprehensive and high throughput analyses, and provided some novel perspectives on the diversity of this ecosystem, which include the following: (a) the first molecular follow up of the long-term microbiota dynamics showed that genetic, environmental and stochastic factors are shaping the microbial community within the gastrointestinal tract, and revealed that some members of Actinobacteria and Bacteroidetes are highly influenced by the genotype of the host, while determening the host-specific microbiota signature; (b) the analysis of the microbial diversity of intestinal contents of patients suffering from irritable bowel syndrome (IBS) and ulcerative colitis (UC) showed that both diseases impacted the microbiota, as its composition was distinctive from that of healthy adults, although the disturbance of the microbiota in relation to UC appeared to be more severe when compared to IBS, and was characterised, in addition to the different relative abundance of numerous members of the microbiota, by dramatically reduced richness of the microbial community; (c) finally, studying the development of the microbial community in a model of the human colon (TIM- 2) provided novel guidelines for improving the handling procedures that will ensure more accurate representation of the microbial diversity of healthy adults. In conclusion, the results indicate that a high throughput and comprehensive studying of the human gastrointestinal microbiota, as facilitated by the application of phylogenetic microarrays is a promising approach for further describing and understanding of this exceptionally relevant microbial ecosystem. Keywords: gastrointestinal microbiota, diversity, phylogenetic microarray, SSU rRNA Contents Outline....................…………………………………………………………......8 Chapter 1 General introduction…………………………………………………………....12 Chapter 2 Characterised microbes of the human gastrointestinal tract……………....24 Chapter 3 Diversity of the human gastrointestinal tract microbiota revisited..…….....50 Chapter 4 A generic design strategy for phylogenetic microarrays based on SSU rRNA gene sequence diversity – the human gastrointestinal microbiota as a case ................................................................................................66 Chapter 5 Evaluating the microbial diversity of an in vitro model of the human large intestine by phylogenetic microarray analysis...................................86 Chapter 6 Dynamics of the adult human gastrointestinal microbiota........................ 100 Chapter 7 Phylogenetic microarray analysis reveals specific faecal microbiota composition in patients suffering from irritable bowel syndrome..............116 Chapter 8 Diversity of the human gastrointestinal microbiota in relation to ulcerative colitis.........................................................................................134 Chapter 9 General discussion...................................................................................154 Bibliography..............................................................................................168 Supplements.............................................................................................192 Outline Evidence for the presence of specific microbes in the human gastrointestinal tract was provided at the end of the XIX century when Teodor Escherich isolated Escherichia coli from children's diarrhoeal faeces. Although this bacterial presence was considered as an infection, it soon became clear that a complex microbial community permanently resides in the gastrointestinal tract, and forms an essential element of the human body. A plethora of functions that contribute to the host's nutrition and health has been assigned to these microbes that collectively are termed microbiota. It has even been suggested that - because of its functions, dimensions and appearance - the microbiota can be considered as a virtual organ within the gastrointestinal tract. Furthermore, it seems that the disturbance of the delicate balance between numerous members of this ecosystem is associated with a number of intestinal and non-intestinal disorders. The appreciation of the importance of the gastrointestinal microbiota has generated significant interest in a further understanding of its dynamics, structure-function relationship and the possibility to modulate those. Although it is prerequisite for understanding and exploiting this ecosystem, the description of its enormous diversity is still not completed. 10 x Outline The work presented in this thesis aims to systematise the generated knowledge on the gastrointestinal microbiota diversity, and provide an improved insight into its relation to health and disease using a newly developed, high-throughput technology. Specific questions that were addressed by each of the chapters are listed below. Chapter 1 summarises the present perception of functions and dimensions of the gastrointestinal microbiota, and provides an overview of the currently available techniques for studying the diversity of this ecosystem. The following two chapters deal with the diversity of the human gastrointestinal microbiota. The results of cultivation-based studies, which are an important source of information because of their extensive use for the analysis of a large amount of samples are summarised in Chapter 2. This chapter presents a thorough analysis of gastrointestinal isolates, embedded in a curated phylogenetic framework, given through a historical perspective with the aim to clarify their importance. An alternative to time-consuming, laborious and expensive cultivation-based analysis of the microbiota’s diversity are molecular approaches, such as those based on small subunit ribosomal RNA (SSU rRNA) gene sequences. The application of molecular techniques has revolutionised our view of many microbial ecosystems, and their impact on the knowledge of human gastrointestinal ecology is portrayed in Chapter 3. This chapter also provides an up-to- date, systematic overview of the gastrointestinal microbiota’s diversity, built by integrating results that were generated by the application of culturing and molecular approaches, and that accumulated during more than a century long studying of this ecosystem. Chapter 4 describes a generic oligonucleotide probe design strategy based on two hypervariable regions of the SSU rRNA gene sequence. This approach is high throughput, can be readily applied to any complex ecosystem, and allows easy addition of probes that target its newly reported inhabitants, which is essential for not yet fully described ecosystems, such as the one that resides in the human intestine. The application of the described strategy on the human gastrointestinal microbiota resulted in the development of the HITChip (Human Intestinal Tract Chip), a phylogenetic microarray that was applied for the analysis of the human intestinal microbiota’s diversity described in the further chapters of this thesis. In vitro fermentation of intestinal contents is a widely used approach to study the metabolic activity of the human gastrointestinal microbiota. To clarify whether such
Recommended publications
  • Fatty Acid Diets: Regulation of Gut Microbiota Composition and Obesity and Its Related Metabolic Dysbiosis
    International Journal of Molecular Sciences Review Fatty Acid Diets: Regulation of Gut Microbiota Composition and Obesity and Its Related Metabolic Dysbiosis David Johane Machate 1, Priscila Silva Figueiredo 2 , Gabriela Marcelino 2 , Rita de Cássia Avellaneda Guimarães 2,*, Priscila Aiko Hiane 2 , Danielle Bogo 2, Verônica Assalin Zorgetto Pinheiro 2, Lincoln Carlos Silva de Oliveira 3 and Arnildo Pott 1 1 Graduate Program in Biotechnology and Biodiversity in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul, Campo Grande 79079-900, Brazil; [email protected] (D.J.M.); [email protected] (A.P.) 2 Graduate Program in Health and Development in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul, Campo Grande 79079-900, Brazil; pri.fi[email protected] (P.S.F.); [email protected] (G.M.); [email protected] (P.A.H.); [email protected] (D.B.); [email protected] (V.A.Z.P.) 3 Chemistry Institute, Federal University of Mato Grosso do Sul, Campo Grande 79079-900, Brazil; [email protected] * Correspondence: [email protected]; Tel.: +55-67-3345-7416 Received: 9 March 2020; Accepted: 27 March 2020; Published: 8 June 2020 Abstract: Long-term high-fat dietary intake plays a crucial role in the composition of gut microbiota in animal models and human subjects, which affect directly short-chain fatty acid (SCFA) production and host health. This review aims to highlight the interplay of fatty acid (FA) intake and gut microbiota composition and its interaction with hosts in health promotion and obesity prevention and its related metabolic dysbiosis.
    [Show full text]
  • Gut Microbiota and Inflammation
    Nutrients 2011, 3, 637-682; doi:10.3390/nu3060637 OPEN ACCESS nutrients ISSN 2072-6643 www.mdpi.com/journal/nutrients Review Gut Microbiota and Inflammation Asa Hakansson and Goran Molin * Food Hygiene, Division of Applied Nutrition, Department of Food Technology, Engineering and Nutrition, Lund University, PO Box 124, SE-22100 Lund, Sweden; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +46-46-222-8327; Fax: +46-46-222-4532. Received: 15 April 2011; in revised form: 19 May 2011 / Accepted: 24 May 2011 / Published: 3 June 2011 Abstract: Systemic and local inflammation in relation to the resident microbiota of the human gastro-intestinal (GI) tract and administration of probiotics are the main themes of the present review. The dominating taxa of the human GI tract and their potential for aggravating or suppressing inflammation are described. The review focuses on human trials with probiotics and does not include in vitro studies and animal experimental models. The applications of probiotics considered are systemic immune-modulation, the metabolic syndrome, liver injury, inflammatory bowel disease, colorectal cancer and radiation-induced enteritis. When the major genomic differences between different types of probiotics are taken into account, it is to be expected that the human body can respond differently to the different species and strains of probiotics. This fact is often neglected in discussions of the outcome of clinical trials with probiotics. Keywords: probiotics; inflammation; gut microbiota 1. Inflammation Inflammation is a defence reaction of the body against injury. The word inflammation originates from the Latin word ―inflammatio‖ which means fire, and traditionally inflammation is characterised by redness, swelling, pain, heat and impaired body functions.
    [Show full text]
  • Aquabacterium Gen. Nov., with Description of Aquabacterium Citratiphilum Sp
    International Journal of Systematic Bacteriology (1999), 49, 769-777 Printed in Great Britain Aquabacterium gen. nov., with description of Aquabacterium citratiphilum sp. nov., Aquabacterium parvum sp. nov. and Aquabacterium commune sp. nov., three in situ dominant bacterial species from the Berlin drinking water system Sibylle Kalmbach,’ Werner Manz,’ Jorg Wecke2 and Ulrich Szewzyk’ Author for correspondence : Werner Manz. Tel : + 49 30 3 14 25589. Fax : + 49 30 3 14 7346 1. e-mail : [email protected]. tu-berlin.de 1 Tech nisc he U nive rsit ;it Three bacterial strains isolated from biofilms of the Berlin drinking water Berlin, lnstitut fur system were characterized with respect to their morphological and Tec hn ischen Umweltschutz, Fachgebiet physiological properties and their taxonomic position. Phenotypically, the Okologie der bacteria investigated were motile, Gram-negative rods, oxidase-positive and Mikroorganismen,D-l 0587 catalase-negative, and contained polyalkanoates and polyphosphate as Berlin, Germany storage polymers. They displayed a microaerophilic growth behaviour and 2 Robert Koch-lnstitut, used oxygen and nitrate as electron acceptors, but not nitrite, chlorate, sulfate Nordufer 20, D-13353 Berlin, Germany or ferric iron. The substrates metabolized included a broad range of organic acids but no carbohydrates at all. The three species can be distinguished from each other by their substrate utilization, ability to hydrolyse urea and casein, cellular protein patterns and growth on nutrient-rich media as well as their temperature, pH and NaCl tolerances. Phylogenetic analysis, based on 165 rRNA gene sequence comparison, revealed that the isolates are affiliated to the /I1 -subclass of Proteobacteria. The isolates constitute three new species with internal levels of DNA relatedness ranging from 44.9 to 51*3O/0.
    [Show full text]
  • Genomic Homogeneity Between Mycobacterium Avium Subsp. Avium and Mycobacterium Avium Subsp
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln U.S. Department of Agriculture: Agricultural Publications from USDA-ARS / UNL Faculty Research Service, Lincoln, Nebraska 2003 Genomic homogeneity between Mycobacterium avium subsp. avium and Mycobacterium avium subsp. paratuberculosis belies their divergent growth rates John P. Bannantine ARS-USDA, [email protected] Qing Zhang 2University of Minnesota, Minneapolis, [email protected] Ling-Ling Li University of Minnesota, Minneapolis, [email protected] Vivek Kapur University of Minnesota, Minneapolis, [email protected] Follow this and additional works at: https://digitalcommons.unl.edu/usdaarsfacpub Bannantine, John P.; Zhang, Qing; Li, Ling-Ling; and Kapur, Vivek, "Genomic homogeneity between Mycobacterium avium subsp. avium and Mycobacterium avium subsp. paratuberculosis belies their divergent growth rates" (2003). Publications from USDA-ARS / UNL Faculty. 2372. https://digitalcommons.unl.edu/usdaarsfacpub/2372 This Article is brought to you for free and open access by the U.S. Department of Agriculture: Agricultural Research Service, Lincoln, Nebraska at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Publications from USDA-ARS / UNL Faculty by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. BMC Microbiology BioMed Central Research article Open Access Genomic homogeneity between Mycobacterium avium subsp. avium and Mycobacterium avium subsp. paratuberculosis belies their
    [Show full text]
  • Nomenclature of Bacteria with Special Reference to the Order Actinomycetales'
    INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY VOL. 21, No. 2 April 1971, pp. 197-206 Printed in U.S.A. Copyright 0 1971 International Association of Microbiological Societies Nomenclature of Bacteria with Special Reference to the Order Actinomycetales' THOMAS G. PRIDHAM Northern Regional Research Laboratory,z Peoria, Illinois 61604 The number of names for streptomycetes that is in the scientific literature now is exceeded only by those for organisms placed in the genus Bacillus Cohn 1872. The genus Streptomyces Waksman and Henrici 1943 may well rank in first place if names in the patent and quasiscientific literature are included. The overwhelming number of names and the lack of a precise definition of a particular species or subspecies, of type or neotype strains, and of certain essential details have brought about problems in assessing the status of many names. The major problems encountered in a 2-year study are discussed, and a simple format is suggested, use of which may help to clarify future nomenclature. Twelve years ago, I presented (29) before ture of Bacteria (20); type strains, where these the First Latin-American Congress for Micro- can be located and obtained, are being as- biology held at Mexico, D.F., some suggestions sembled and recharacterized (35 -38) through on establishing a logical order in streptomycete the International Streptomyces Project, and a classification. minumum set of substrata and tests have been (i) Compilation and evaluation of available recommended for description of A ctino- literature on nomenclature and characterization mycetales in patents (1 1, 12). of streptomycetes. One item upon which insufficient attention (ii) Decision on the proper code of nomen- has been focused is nomenclature.
    [Show full text]
  • Downloads/Bin/Fastq Quality Filter -Q20 -P90 -Q33
    Biological Reduction of Selenium Oxyanions in the Presence of Nitrate anions using Anaerobic Microbes by Gaurav Subedi B.Sc., Jacobs University Bremen, 2010 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE in THE FACULTY OF GRADUATE AND POSTDOCTORAL STUDIES (Chemical and Biological Engineering) THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver) July 2016 © Gaurav Subedi, 2016 Abstract Biological selenium reduction has emerged as a viable solution for the removal of toxic selenium from the environment. However, the presence of nitrate hinders selenium reduction by acting as a competitive electron acceptor. The present thesis investigated the use of local mine-impacted sediment as an inoculum for selenium reduction and studied the affect of nitrate on the removal of selenium. Sediment samples, impacted by mining activities, were collected from two vastly different sites of the Elk River Valley. These sediments namely; Goddard Marsh and Mature Tailing Coal, were enriched for selenium reducing bacterial consortium under high selenium and varying nitrate concentrations to put additional selection pressure. Ultimately, two cultures from Goddard Marsh enriched under low and high nitrate condition as well as one culture from Mature Tailing Coal enriched under moderate nitrate condition were used to access the affect of nitrate on selenium reduction using central composite design matrix. The extent of Se reduction was highest in the Goddard Marsh enrichment with no nitrate while enrichment with moderate and high nitrate reduced selenium poorly. ANOVA results from the CCD experiment in Goddard Marsh enrichment with no nitrate indicated no affect of nitrate in Se reduction. Two primer sets targeting the selenate redutase (serA) from Thauera selenatis and nitrite reductase (nirK) from denitrifying population were used to quantify the population of selenium reducing and denitrifying population in the CCD experiment.
    [Show full text]
  • Pdfs/ Ommended That Initial Cultures Focus on Common Pathogens, Pscmanual/9Pscssicurrent.Pdf)
    Clinical Infectious Diseases IDSA GUIDELINE A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya J. Michael Miller,1 Matthew J. Binnicker,2 Sheldon Campbell,3 Karen C. Carroll,4 Kimberle C. Chapin,5 Peter H. Gilligan,6 Mark D. Gonzalez,7 Robert C. Jerris,7 Sue C. Kehl,8 Robin Patel,2 Bobbi S. Pritt,2 Sandra S. Richter,9 Barbara Robinson-Dunn,10 Joseph D. Schwartzman,11 James W. Snyder,12 Sam Telford III,13 Elitza S. Theel,2 Richard B. Thomson Jr,14 Melvin P. Weinstein,15 and Joseph D. Yao2 1Microbiology Technical Services, LLC, Dunwoody, Georgia; 2Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; 3Yale University School of Medicine, New Haven, Connecticut; 4Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland; 5Department of Pathology, Rhode Island Hospital, Providence; 6Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill; 7Department of Pathology, Children’s Healthcare of Atlanta, Georgia; 8Medical College of Wisconsin, Milwaukee; 9Department of Laboratory Medicine, Cleveland Clinic, Ohio; 10Department of Pathology and Laboratory Medicine, Beaumont Health, Royal Oak, Michigan; 11Dartmouth- Hitchcock Medical Center, Lebanon, New Hampshire; 12Department of Pathology and Laboratory Medicine, University of Louisville, Kentucky; 13Department of Infectious Disease and Global Health, Tufts University, North Grafton, Massachusetts; 14Department of Pathology and Laboratory Medicine, NorthShore University HealthSystem, Evanston, Illinois; and 15Departments of Medicine and Pathology & Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey Contents Introduction and Executive Summary I.
    [Show full text]
  • WO 2018/064165 A2 (.Pdf)
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/064165 A2 05 April 2018 (05.04.2018) W !P O PCT (51) International Patent Classification: Published: A61K 35/74 (20 15.0 1) C12N 1/21 (2006 .01) — without international search report and to be republished (21) International Application Number: upon receipt of that report (Rule 48.2(g)) PCT/US2017/053717 — with sequence listing part of description (Rule 5.2(a)) (22) International Filing Date: 27 September 2017 (27.09.2017) (25) Filing Language: English (26) Publication Langi English (30) Priority Data: 62/400,372 27 September 2016 (27.09.2016) US 62/508,885 19 May 2017 (19.05.2017) US 62/557,566 12 September 2017 (12.09.2017) US (71) Applicant: BOARD OF REGENTS, THE UNIVERSI¬ TY OF TEXAS SYSTEM [US/US]; 210 West 7th St., Austin, TX 78701 (US). (72) Inventors: WARGO, Jennifer; 1814 Bissonnet St., Hous ton, TX 77005 (US). GOPALAKRISHNAN, Vanch- eswaran; 7900 Cambridge, Apt. 10-lb, Houston, TX 77054 (US). (74) Agent: BYRD, Marshall, P.; Parker Highlander PLLC, 1120 S. Capital Of Texas Highway, Bldg. One, Suite 200, Austin, TX 78746 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • Glycomyces, a New Genus of the Actinomycetales D
    INTERNATIONALJOURNAL OF SYSTEMATICBACTERIOLOGY, Oct. 1985, p. 417-421 Vol. 35, No. 4 0020-7713/85/040417-05$02.00/0 Glycomyces, a New Genus of the Actinomycetales D. P. LABEDA,l* R. T. TESTA,2 M. P. LECHEVALIER,3 AND H. A. LECHEVALIER3 U. S. Department of Agriculture, Agricultural Research Sewice, Northern Regional Research Center, Peoria, Illinois 61604'; Medical Research Division, American Cyanamid Co., Pearl River, New York 109652; and Waksman Institute of Microbiology, Rutgers, The State University, Piscataway, New Jersey 088543 We describe two species of the new genus Glycomyces, Glycomyces harbinensis sp. nov. and Glycomyces rutgersensis sp. nov. Members of this genus are aerobic, produce nonfragmenting vegetative hyphae, and form chains of conidia on aerial sporophores. The cell walls are type I1 (rneso-diaminopimelic acid and glycine are present), and the whole-cell sugar patterns are type D (xylose and arabinose are present). The phospholipid pattern of both species is type P-I (no nitrogenous phospholipids). The guanine-plus-cytosine content of the deoxyribonucleic acid ranges from 71 to 73 mol%. The type strain of type species G. harbinensis is strain NRRL 15337 (= LL-D05139), and the type strain of G. rutgersensis is strain NRRL B-16106 (= LL-1-20). During the course of isolation of actinomycete strains Gordon et al. (8). Esculin hydrolysis was evaluated by the from soil for an antibiotic screening program, a novel isolate method of Williams et al. (27), and Tween 80 hydrolysis was was obtained from a soil sample from Harbin, People's evaluated by the method of Sierra (26). Phosphatase activity Republic of China.
    [Show full text]
  • The Coliform Kind: E. Coli and Its “Cousins” the Good, the Bad, and the Deadly
    Scholars Crossing Faculty Publications and Presentations Department of Biology and Chemistry 10-3-2018 The Coliform Kind: E. coli and Its “Cousins” The Good, the Bad, and the Deadly Alan L. Gillen Liberty University, [email protected] Matthew Augusta Follow this and additional works at: https://digitalcommons.liberty.edu/bio_chem_fac_pubs Part of the Biology Commons Recommended Citation Gillen, Alan L. and Augusta, Matthew, "The Coliform Kind: E. coli and Its “Cousins” The Good, the Bad, and the Deadly" (2018). Faculty Publications and Presentations. 125. https://digitalcommons.liberty.edu/bio_chem_fac_pubs/125 This Article is brought to you for free and open access by the Department of Biology and Chemistry at Scholars Crossing. It has been accepted for inclusion in Faculty Publications and Presentations by an authorized administrator of Scholars Crossing. For more information, please contact [email protected]. The Coliform Kind: E. coli and Its “Cousins” The Good, the Bad, and the Deadly by Dr. Alan L. Gillen and Matthew Augusta on October 3, 2018 Abstract Even though some intestinal bacteria strains are pathogenic and even deadly, most coliforms strains still show evidence of being one of God’s “very good” creations. In fact, bacteria serve an intrinsic role in the colon of the human body. These bacteria aid in the early development of the immune system and stimulate up to 80% of immune cells in adults. In addition, digestive enzymes, Vitamins K and B12, are produced byEscherichia coli and other coliforms. E. coli is the best-known bacteria that is classified as coliforms. The term “coliform” name was historically attributed due to the “Bacillus coli-like” forms.
    [Show full text]
  • Citrobacter Braakii
    & M cal ed ni ic li a l C G f e Trivedi et al., J Clin Med Genom 2015, 3:1 o n l o a m n r DOI: 10.4172/2472-128X.1000129 i u c s o Journal of Clinical & Medical Genomics J ISSN: 2472-128X ResearchResearch Article Article OpenOpen Access Access Phenotyping and 16S rDNA Analysis after Biofield Treatment on Citrobacter braakii: A Urinary Pathogen Mahendra Kumar Trivedi1, Alice Branton1, Dahryn Trivedi1, Gopal Nayak1, Sambhu Charan Mondal2 and Snehasis Jana2* 1Trivedi Global Inc., Eastern Avenue Suite A-969, Henderson, NV, USA 2Trivedi Science Research Laboratory Pvt. Ltd., Chinar Fortune City, Hoshangabad Rd., Madhya Pradesh, India Abstract Citrobacter braakii (C. braakii) is widespread in nature, mainly found in human urinary tract. The current study was attempted to investigate the effect of Mr. Trivedi’s biofield treatment on C. braakii in lyophilized as well as revived state for antimicrobial susceptibility pattern, biochemical characteristics, and biotype number. Lyophilized vial of ATCC strain of C. braakii was divided into two parts, Group (Gr.) I: control and Gr. II: treated. Gr. II was further subdivided into two parts, Gr. IIA and Gr. IIB. Gr. IIA was analysed on day 10 while Gr. IIB was stored and analysed on day 159 (Study I). After retreatment on day 159, the sample (Study II) was divided into three separate tubes. First, second and third tube was analysed on day 5, 10 and 15, respectively. All experimental parameters were studied using automated MicroScan Walk-Away® system. The 16S rDNA sequencing of lyophilized treated sample was carried out to correlate the phylogenetic relationship of C.
    [Show full text]
  • Supplementary File 1
    Supplementary The Effect of Increasing Inclusion Levels of a Fucoidan Rich Extract Derived from Ascophyllum nodosum on Growth Performance and Aspects of Intestinal Health of Pigs Post-Weaning Ruth Rattigan 1, Stafford Vigors 1, Gaurav Rajauria 1, Torres Sweeney 2, Kevin Thornton 2 and John V O’Doherty 1,* Supplementary document 1. Alpha diversity & gene expression Figure S1. The effect of fucoidan supplementation at 250ppm on Observed, Shannon and Simpson measures of alpha diversity in caecal and colonic digesta. Table DS1. Effect of fucoidan on gene expression in the duodenum (Least-square means with their standard errors) Group Gene Basal Fucoidan SEM P value 250ppm Digestive SI 23195.53 21920.53 3734.92 0.813 enzymes CNDP1 220.76 195.56 57.42 0.761 FABP2 64101.33 63277.94 13214.97 0.966 SLC2A1 340.44 103.05 47.20 0.364 SLC2A2 3501.49 3760.72 603.38 0.766 SLC2A5 979.44 789.62 90.78 0.163 SLC2A7 508.99 496.96 88.62 0.925 SLC2A8 226.76 401.46 66.18 0.083 Nutrient SLC16A1 2246.59 2698.03 218.08 0.165 transporters SLC15A1 3936.03 4139.35 585.09 0.810 SLC5A1 11917.91 11381.36 1652.19 0.822 SLC16A10 649.47 581.32 71.64 0.512 SLC6A19 2623.95 2733.15 213.52 0.723 SLC7A1 157.24 181.69 12.93 0.202 SLC5A8 3214.00 4059.56 199.78 0.010 GLP2R 153.47 163.79 10.00 0.479 Appetite GCG 723.21 264.69 275.57 0.261 regulators CCK 825.90 813.21 98.49 0.929 CLDN3 2284.64 2545.28 135.22 0.194 CLDN5 65.53 55.71 3.18 0.047 Tight junctions OCLN 2290.33 2235.59 148.52 0.798 TJP1 1050.29 1051.15 28.50 0.983 NFKB1 561.69 598.47 16.04 0.127 IFNG 90.61 110.40 16.36
    [Show full text]